Home
Lynx1 Capital Management reported a 5.4% stake in iBio · 2,807,016 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.4%
- Last report
- 0% · filed 26/02/17
- Shares held
- 2,807,016 sh
- Class
- Common Stock, $0.001 par value per share
- Stock
- iBio
- Holder
- Lynx1 Capital Management
- Event date
- 26/06/30
- Filed
- 26/08/14
5.4% stake · +5.4pp from the last report
- Stake
- 5.4%
- Last report
- 0%
- Since last report
- +5.4pp
iBio trades, last 26 weeks
What else happened in iBio around then
Filed or reported within 30 days of the trade day · 05/31~07/30Lynx1 Capital Management's other 5% stake reports
- Lynx1 Capital Management
5% stakeTScan Therapeutics
5% stakeTScan Therapeutics
TCRX
13.1% stake
20,519,148 sh
13.1% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeStoke Therapeutics
5% stakeStoke Therapeutics
STOK
6.5% stake
4,038,404 sh
6.5% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeC4 Therapeutics
5% stakeC4 Therapeutics
CCCC
9.99% stake
15,423,691 sh
9.99% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeGH Research
5% stakeGH Research
GHRS
19.3% stake
13,263,288 sh
19.3% stake
Filed 08/14
- Lynx1 Capital Management
5% stakePrecision Biosciences
5% stakePrecision Biosciences
DTIL
5.4% stake
1,390,611 sh
5.4% stake
Filed 07/20
